N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide

C23H23N3O — CID 51352792

IUPACN-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide
SMILESO=C(Cc1ccccc1)Nc1ccc(-n2nc(C3CC3)cc2C2CC2)cc1
InChIInChI=1S/C23H23N3O/c27-23(14-16-4-2-1-3-5-16)24-19-10-12-20(13-11-19)26-22(18-8-9-18)15-21(25-26)17-6-7-17/h1-5,10-13,15,17-18H,6-9,14H2,(H,24,27)
InChIKeyOUJQSLUNDPQAFU-UHFFFAOYSA-N
MW357.46 g/mol
LogP4.81
Rot. Bonds6

About N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide

N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide (PubChem CID 51352792) has the molecular formula C23H23N3O and a molecular weight of 357.46 g/mol. Its IUPAC name is N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide.

Molecular Properties

Compound NameN-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide
PubChem CID51352792
Molecular FormulaC23H23N3O
Molecular Weight357.46 g/mol
Exact Mass357.18
IUPAC NameN-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide
SMILESO=C(Cc1ccccc1)Nc1ccc(-n2nc(C3CC3)cc2C2CC2)cc1
InChIInChI=1S/C23H23N3O/c27-23(14-16-4-2-1-3-5-16)24-19-10-12-20(13-11-19)26-22(18-8-9-18)15-21(25-26)17-6-7-17/h1-5,10-13,15,17-18H,6-9,14H2,(H,24,27)
InChIKeyOUJQSLUNDPQAFU-UHFFFAOYSA-N
XLogP4.81
TPSA46.92 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds6
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500357.46
LogP ≤ 54.81
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1H-Pyrazole-4-acetamide, 3,5-dimethyl-1-phenyl-N-(phenylmethyl)-
CID 3079322
N-isopropyl-5-methyl-1,3-diphenyl-1H-pyrazole-4-carboxamide
CID 759525
N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazole-1-yl]phenyl]-2-fluorobenzamide
CID 10202049
N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazole-1-yl]phenyl]-2,3-difluorobenzamide
CID 10503003
N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazole-1-yl]phenyl]-2,5-difluorobenzamide
CID 10622741
N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazole-1-yl]phenyl]-2,3,5-trifluorobenzamide
CID 10718489
2-[3,5-dimethyl-1-[3-[[(1S,2S)-2-phenylcyclopropanecarbonyl]amino]phenyl]pyrazol-4-yl]acetic acid
CID 71624847
3-Methyl-1-phenyl-4,6-dihydropyrazolo(4,3-d)(1)benzazepin-5(1H)-one
CID 378957
2-(3,5-dimethyl-1-phenylpyrazol-4-yl)-N-(2-phenylpropan-2-yl)acetamide
CID 46887106
N-[2-(3,5-Dimethyl-pyrazol-1-yl)-2-oxo-ethyl]-2,2-diphenyl-acetamide
CID 787894
N-[[5-(2-methylpropyl)-1-phenylpyrazol-3-yl]methyl]-3-(2-phenylacetyl)-3-azabicyclo[3.1.0]hexane-6-carboxamide
CID 86292750
5-methyl-1,3-diphenyl-1H-pyrazole-4-carboxamide
CID 843369

Frequently Asked Questions

What is the IUPAC name of N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide?
The IUPAC name of N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide (CID 51352792) is N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide.
What is the SMILES notation for N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide?
The canonical SMILES for N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide is O=C(Cc1ccccc1)Nc1ccc(-n2nc(C3CC3)cc2C2CC2)cc1.
What is the InChIKey of N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide?
The InChIKey is OUJQSLUNDPQAFU-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H23N3O/c27-23(14-16-4-2-1-3-5-16)24-19-10-12-20(13-11-19)26-22(18-8-9-18)15-21(25-26)17-6-7-17/h1-5,10-13,15,17-18H,6-9,14H2,(H,24,27).
What are the key properties of N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide?
N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide has a molecular weight of 357.46 g/mol, XLogP of 4.81, 6 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(3,5-dicyclopropylpyrazol-1-yl)phenyl]-2-phenylacetamide is sourced from PubChem (CID 51352792), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).